$6.67
25.14% yesterday
Nasdaq, Aug 12, 10:15 pm CET
ISIN
US0088751062
Symbol
DOMH

AIkido Pharma Inc Stock price

$6.67
+1.32 24.67% 1M
+0.07 1.03% 6M
+5.72 605.07% YTD
+5.12 331.10% 1Y
+0.76 12.86% 3Y
-9.31 58.26% 5Y
-270.62 97.59% 10Y
-429,099.38 100.00% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+1.34 25.14%
ISIN
US0088751062
Symbol
DOMH
Industry

Key metrics

Basic
Market capitalization
$78.1m
Enterprise Value
$59.2m
Net debt
positive
Cash
$18.9m
Shares outstanding
14.6m
Valuation (TTM | estimate)
P/E
negative | -
P/S
3.1 | -
EV/Sales
2.4 | -
EV/FCF
negative
P/B
1.8
Financial Health
Equity Ratio
84.6%
Return on Equity
-36.9%
ROCE
-88.0%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$24.9m | -
EBITDA
$-40.6m | -
EBIT
$-40.7m | -
Net Income
$-41.8m | -
Free Cash Flow
$-5.3m
Growth (TTM | estimate)
Revenue
632.1% | -
EBITDA
-96.7% | -
EBIT
-96.2% | -
Net Income
-70.0% | -
Free Cash Flow
80.3%
Margin (TTM | estimate)
Gross
-
EBITDA
-163.2% | -
EBIT
-163.6%
Net
-167.7% | -
Free Cash Flow
-21.3%
More
EPS
$-3.9
FCF per Share
$-0.4
Short interest
5.2%
Employees
29
Rev per Employee
$630.0k
Show more

Is AIkido Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

AIkido Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a AIkido Pharma Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a AIkido Pharma Inc forecast:

Buy
86%
Hold
14%

Financial data from AIkido Pharma Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
25 25
632% 632%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 66 66
171% 171%
264%
- Research and Development Expense - -
-
-
-41 -41
97% 97%
-163%
- Depreciation and Amortization 0.11 0.11
10% 10%
0%
EBIT (Operating Income) EBIT -41 -41
96% 96%
-164%
Net Profit -42 -42
70% 70%
-168%

In millions USD.

Don't miss a Thing! We will send you all news about AIkido Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AIkido Pharma Inc Stock News

Neutral
PRNewsWire
about 11 hours ago
Revenue of $34.1 Million, up 520% Closed 46 Transactions in Q2 with Total Raise Amount of More Than $288.9 Million between both our Private & Public Transactions NEW YORK , Aug. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH), today announced financial results for the quarter that ended June 30, 2025. The results underscore a significant inflection point for the Company, which de...
Neutral
Accesswire
7 days ago
NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Dominari Holdings Inc. (Nasdaq:DOMH) today announced that its wholly owned subsidiary, Dominari Securities LLC, and all advisors thereto, no longer work with, advise or are associated with in any way, the following entities: Resolution Minerals LtdLevel 4, 29-31 King William StreetAdelaide, South Australia 5000 Oakley CapitalL39, Aurora Pla...
Neutral
Investors Business Daily
8 days ago
Skilled S&P 500 investors know it's best to avoid penny stocks. Even so, there's a rise in speculation in the market.
More AIkido Pharma Inc News

Company Profile

Spherix Incorporated, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company's platform consists of patented technology from leading universities and researchers and in the process of developing an innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York.

Head office United States
CEO Anthony Hayes
Employees 29
Founded 1967
Website www.dominariholdings.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today